PANC (Panacos Pharmaceuticals) FCF Margin % : -32,508.33% (As of Sep. 2008)

View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Panacos Pharmaceuticals's Free Cash Flow for the three months ended in Sep. 2008 was $-7.80 Mil. Panacos Pharmaceuticals's Revenue for the three months ended in Sep. 2008 was $0.02 Mil. Therefore, Panacos Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2008 was -32,508.33%.

As of today, Panacos Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for Panacos Pharmaceuticals's FCF Margin % or its related term are showing as below:

PANC' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: -31558.59

PANC's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -143.325 vs PANC: -31558.59

Panacos Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Panacos Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals FCF Margin % Chart

Panacos Pharmaceuticals Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

FCF Margin %

Get a 7-Day Free Trial

-367.25

-736.65

-2,077.79

-10,615.85

-17,268.33

Panacos Pharmaceuticals Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
FCF Margin %	Get a 7-Day Free Trial															-23,176.67	-32,454.55	-24,285.71	-43,338.89	-32,508.33

Competitive Comparison of Panacos Pharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Panacos Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacos Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacos Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Panacos Pharmaceuticals's FCF Margin % falls into.

Panacos Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Panacos Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2007 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2007 )	/	Revenue (A: Dec. 2007 )
	=	-31.083	/	0.18
	=	-17,268.33 %

Panacos Pharmaceuticals's FCF Margin for the quarter that ended in Sep. 2008 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2008 )	/	Revenue (Q: Sep. 2008 )
	=	-7.802	/	0.024
	=	-32,508.33 %

Panacos Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacos Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

134 Coolidge Avenue, Watertown, MA, USA, 02472

Website

http://www.panacos.com

Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals Headlines

No Headlines